Neuroprotective Products Market Report

Global and Region Neuroprotective Products Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：167
  • REPORT CODE：GMM925022
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Neuroprotective Products consist of medications that can be used to protect or preserve the neuronal cells of the brain from degeneration, stress, and injury, which can impair cognitive functions. 

    The report details the trend, potential and market size of Neuroprotective Products market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Neuroprotective Productsmarket, defines the market attractiveness level of Neuroprotective Products market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Neuroprotective Products industry, describes the types of Neuroprotective Products market, the applications of major players and the market size, and deeply analyzes the current situation of the global Neuroprotective Products market and the development prospects and opportunities of Neuroprotective Products industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Neuroprotective Products market in Chapter 13.

    By Player:

    • Neuren Pharmaceuticals (Australia)

    • BHRPharma (Thailand)

    • Allon therapeutics (Canada)

    • NeuroVive Pharmaceutical (Sweden)

    • Ceregene (USA)

    • Genervon Biopharmaceuticals (Canada)

    By Type:

    • Cholinesterase inhibitors

    • NMDA receptor antagonists

    • Others

    By End-User:

    • Alzheimer's disease

    • Multiple sclerosis

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Neuroprotective Products Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Neuroprotective Products Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Neuroprotective Products Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Neuroprotective Products Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Neuroprotective Products Market Analysis and Outlook to 2022

    • 7.1 Global Neuroprotective Products Consumption (2017-2022)

    • 7.2 United States Neuroprotective Products Consumption (2017-2022)

    • 7.3 Europe Neuroprotective Products Consumption (2017-2022)

    • 7.4 China Neuroprotective Products Consumption (2017-2022)

    • 7.5 Japan Neuroprotective Products Consumption (2017-2022)

    • 7.6 India Neuroprotective Products Consumption (2017-2022)

    • 7.7 South Korea Neuroprotective Products Consumption (2017-2022)

    8 Region and Country-wise Neuroprotective Products Market Analysis and Outlook to 2028

    • 8.1 Global Neuroprotective Products Consumption Forecast (2022-2028)

    • 8.2 United States Neuroprotective Products Consumption Forecast (2022-2028)

    • 8.3 Europe Neuroprotective Products Consumption Forecast (2022-2028)

    • 8.4 China Neuroprotective Products Consumption Forecast (2022-2028)

    • 8.5 Japan Neuroprotective Products Consumption Forecast (2022-2028)

    • 8.6 India Neuroprotective Products Consumption Forecast (2022-2028)

    • 8.7 South Korea Neuroprotective Products Consumption Forecast (2022-2028)

    9 Global Neuroprotective Products Market Outlook by Types and Applications to 2022

    • 9.1 Global Neuroprotective Products Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Cholinesterase inhibitors Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global NMDA receptor antagonists Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Neuroprotective Products Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Alzheimer's disease Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Multiple sclerosis Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Neuroprotective Products Market Outlook by Types and Applications to 2028

    • 10.1 Global Neuroprotective Products Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Cholinesterase inhibitors Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global NMDA receptor antagonists Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Neuroprotective Products Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Alzheimer's disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Multiple sclerosis Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Neuroprotective Products Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Neuroprotective Products Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Neuroprotective Products Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Neuroprotective Products Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Neuroprotective Products Market Competitive Analysis

    • 14.1 Neuren Pharmaceuticals (Australia)

      • 14.1.1 Neuren Pharmaceuticals (Australia) Company Details

      • 14.1.2 Neuren Pharmaceuticals (Australia) Neuroprotective Products Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Neuren Pharmaceuticals (Australia) Neuroprotective Products Product and Service

    • 14.2 BHRPharma (Thailand)

      • 14.2.1 BHRPharma (Thailand) Company Details

      • 14.2.2 BHRPharma (Thailand) Neuroprotective Products Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 BHRPharma (Thailand) Neuroprotective Products Product and Service

    • 14.3 Allon therapeutics (Canada)

      • 14.3.1 Allon therapeutics (Canada) Company Details

      • 14.3.2 Allon therapeutics (Canada) Neuroprotective Products Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Allon therapeutics (Canada) Neuroprotective Products Product and Service

    • 14.4 NeuroVive Pharmaceutical (Sweden)

      • 14.4.1 NeuroVive Pharmaceutical (Sweden) Company Details

      • 14.4.2 NeuroVive Pharmaceutical (Sweden) Neuroprotective Products Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 NeuroVive Pharmaceutical (Sweden) Neuroprotective Products Product and Service

    • 14.5 Ceregene (USA)

      • 14.5.1 Ceregene (USA) Company Details

      • 14.5.2 Ceregene (USA) Neuroprotective Products Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Ceregene (USA) Neuroprotective Products Product and Service

    • 14.6 Genervon Biopharmaceuticals (Canada)

      • 14.6.1 Genervon Biopharmaceuticals (Canada) Company Details

      • 14.6.2 Genervon Biopharmaceuticals (Canada) Neuroprotective Products Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Genervon Biopharmaceuticals (Canada) Neuroprotective Products Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Neuroprotective Products

    • Figure Neuroprotective Products Picture

    • Table Global Neuroprotective Products Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Neuroprotective Products Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Neuroprotective Products Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Neuroprotective Products Consumption by Country (2017-2022)

    • Figure United States Neuroprotective Products Consumption and Growth Rate (2017-2022)

    • Table Europe Neuroprotective Products Consumption and Growth Rate (2017-2022)

    • Figure China Neuroprotective Products Consumption and Growth Rate (2017-2022)

    • Figure Japan Neuroprotective Products Consumption and Growth Rate (2017-2022)

    • Figure India Neuroprotective Products Consumption and Growth Rate (2017-2022)

    • Figure South Korea Neuroprotective Products Consumption and Growth Rate (2017-2022)

    • Figure Global Neuroprotective Products Consumption Forecast by Country (2022-2028)

    • Figure United States Neuroprotective Products Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Neuroprotective Products Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Neuroprotective Products Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Neuroprotective Products Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Neuroprotective Products Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Neuroprotective Products Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cholinesterase inhibitors Consumption and Growth Rate (2017-2022)

    • Figure Global NMDA receptor antagonists Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Alzheimer's disease Consumption and Growth Rate (2017-2022)

    • Figure Global Multiple sclerosis Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Cholinesterase inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global NMDA receptor antagonists Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Alzheimer's disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Multiple sclerosis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Neuroprotective Products Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Neuroprotective Products Export by Region (Top 5 Countries) (2017-2028)

    • Table Neuren Pharmaceuticals (Australia) (Foundation Year, Company Profile and etc.)

    • Table Neuren Pharmaceuticals (Australia) Neuroprotective Products Sales, Price, Value and Gross Profit (2017-2022)

    • Table Neuren Pharmaceuticals (Australia) Neuroprotective Products Product and Service

    • Table BHRPharma (Thailand) (Foundation Year, Company Profile and etc.)

    • Table BHRPharma (Thailand) Neuroprotective Products Sales, Price, Value and Gross Profit (2017-2022)

    • Table BHRPharma (Thailand) Neuroprotective Products Product and Service

    • Table Allon therapeutics (Canada) (Foundation Year, Company Profile and etc.)

    • Table Allon therapeutics (Canada) Neuroprotective Products Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allon therapeutics (Canada) Neuroprotective Products Product and Service

    • Table NeuroVive Pharmaceutical (Sweden) (Foundation Year, Company Profile and etc.)

    • Table NeuroVive Pharmaceutical (Sweden) Neuroprotective Products Sales, Price, Value and Gross Profit (2017-2022)

    • Table NeuroVive Pharmaceutical (Sweden) Neuroprotective Products Product and Service

    • Table Ceregene (USA) (Foundation Year, Company Profile and etc.)

    • Table Ceregene (USA) Neuroprotective Products Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ceregene (USA) Neuroprotective Products Product and Service

    • Table Genervon Biopharmaceuticals (Canada) (Foundation Year, Company Profile and etc.)

    • Table Genervon Biopharmaceuticals (Canada) Neuroprotective Products Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genervon Biopharmaceuticals (Canada) Neuroprotective Products Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US